A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.
about
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Pharmacological versus microvascular decompression approaches for the treatment of trigeminal neuralgia: clinical outcomes and direct costsPregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.Economic impact of a triptan Rx-to-OTC switch in six EU countries.Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain.Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.Pregabalin in neuropathic pain: evidences and possible mechanisms.Drug safety evaluation of pregabalin.Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain.Platelet-rich plasma and the elimination of neuropathic pain.Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.A systematic review of pharmacoeconomic studies for pregabalin.Antinociceptive effects of gentiopicroside on neuropathic pain induced by chronic constriction injury in mice: a behavioral and electrophysiological study.Use and satisfaction with the Healthcare System of the chronic pain patients in Spain: results from a nationwide study.Neuroprotective Effect of Matrine in Mouse Model of Vincristine-Induced Neuropathic Pain.Role of the neuroendocrine antimicrobial peptide catestatin in innate immunity and pain.Cost analysis of adding pregabalin or gabapentin to the management of community-treated patients with peripheral neuropathic pain.Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice.
P2860
Q33949565-B71B3851-1460-494B-A64D-FB99FD97643BQ34632537-0A62F4D1-5C43-4295-9AE5-E56046C6460EQ34753719-37F169DB-E093-4BD5-B589-630A5EBD03EDQ35075662-10627E83-4459-43C9-96FE-6D53855918BEQ36536768-34FC14D6-C55E-4D5D-AF24-42ACBE7B7F86Q36701353-05C2919E-48C4-4079-9559-A329C275928AQ37115112-23624F4E-8997-4158-95AC-A272501DFAC9Q37559818-2D05F4CF-814E-4C9A-8FAC-9584C02D2DB2Q37999052-E3849A5C-479E-43D3-B2AE-F5598AF3ABB4Q38058792-1BC1003D-8F1E-4A26-BB6C-10B4FF437A5EQ38119874-8786DDA0-363A-4BBA-ADDA-5F8775D0EE22Q38175904-AB1FB290-9BAE-4460-9C1E-DEF07003DA29Q38210750-4C6B7C93-9985-49F4-A723-F40C7946741DQ39769371-EF75A0C4-9FAC-41A1-8FE0-6D51FF26073BQ47912505-B7ECBCC2-62A2-4551-8E32-080DB6DB1769Q48946163-257E99BB-A03D-4361-A8CB-835AF3B04CDCQ49579336-6B364D0B-907E-43EE-8D61-C673857F3741Q51419600-387D62B0-0505-41F0-9548-807A2F851683Q51766749-7333D947-B1E4-4062-8CBB-A315D5D00F02
P2860
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A cost-consequences analysis o ...... tice in primary care settings.
@ast
A cost-consequences analysis o ...... tice in primary care settings.
@en
type
label
A cost-consequences analysis o ...... tice in primary care settings.
@ast
A cost-consequences analysis o ...... tice in primary care settings.
@en
prefLabel
A cost-consequences analysis o ...... tice in primary care settings.
@ast
A cost-consequences analysis o ...... tice in primary care settings.
@en
P2093
P2860
P356
P1433
P1476
A cost-consequences analysis o ...... tice in primary care settings.
@en
P2093
Ana Navarro
Concepción Pérez
Javier Rejas
María T Saldaña
Sandra Torrades
P2860
P2888
P356
10.1186/1471-2377-11-7
P577
2011-01-20T00:00:00Z
P5875
P6179
1038006120